Inactive Instrument

POZEN Inc. Stock

Equities

US73941U1025

Pharmaceuticals

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Press releases POZEN Inc.

POZEN : Announces Stockholder Approval of its Transaction with Tribute Pharmaceuticals Canada Inc.	16-02-02	PR
POZEN : And Tribute Announce Plan To Proceed With Merger To Form Aralez Pharmaceuticals	15-12-07	PR
POZEN : and Tribute Announce Plan to Proceed With Merger to Form Aralez Pharmaceuticals	15-12-07	MW
POZEN : Reports Third Quarter 2015 Results	15-11-09	BU
POZEN : and Tribute Announce Effectiveness of Registration Statement on Form S-4	15-11-06	BU

More press releases

News in other languages on POZEN Inc.

Sanofi : Pozen met fin à son accord de commercialisation sur 2 médicaments en développement	14-12-01
SANOFI : obtient les droits de commercialisation de médicaments développés par Pozen	13-09-05

Managers and Directors - POZEN Inc.

Managers	Title	Age	Since
John E. Barnhardt ADM	Chief Administrative Officer	74	-

Company Profile

Sector

Pharmaceuticals

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ELI LILLY AND COMPANY	+27.92%	659B
NOVO NORDISK A/S	+27.68%	557B
JOHNSON & JOHNSON	-4.59%	359B
MERCK & CO., INC.	+16.38%	322B
ABBVIE INC.	+9.39%	297B
ASTRAZENECA PLC	+6.30%	215B
NOVARTIS AG	+4.80%	210B
ROCHE HOLDING AG	-6.05%	200B
PFIZER, INC.	-8.58%	149B

Other Pharmaceuticals

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer